Samsung Electronics beat analyst estimates for profit in the first quarter, but warned of continued fallout from semiconductor shortages as the global economy recovers from the Covid-19 pandemic.

The transfers come as Zoom's shares have nearly tripled in the past 12 months, as the COVID-19 pandemic drove an increasing number of students and professionals to connect online.

The Organisation for Economic Cooperation and Development said the world economy is likely to expand by 5.6% in 2021.

Germany has asked Taiwan to persuade Taiwanese manufacturers to help ease a shortage of semiconductor chips in the auto sector which is hampering its fledgling economic recovery from the COVID-19 pandemic.

The coronavirus vaccine developed by the University of Oxford is highly effective at stopping people developing Covid-19 symptoms, a large trial shows.

Texas Instruments reported its first quarterly revenue growth in nearly two years on Tuesday, a rebound the chipmaker credited to people stuck at home splurging on electronic gadgets for remote work and entertainment during the COVID-19 pandemic.

Nokia has created an automated system that uses a thermal camera and real-time video analytics to determine if a person has COVID-19 symptoms and is wearing a mask, part of efforts to protect employees as they return to work.

Samsung Electronics unveiled its latest Galaxy Note smartphone and new version of its foldable phone, the Z Fold 2, on Wednesday, hoping to regain ground against rivals Huawei and Apple as the smartphone market begins to recover from its COVID-19 slump.

Microsoft investors are confident in its ability to weather economic storms, but its latest results will shed light on how COVID-19 has impacted its business for better and worse.

A Covid-19 vaccine developed by the biotechnology company Moderna in partnership with the National Institutes of Health has been found to induce immune responses in all of the volunteers who received it in a Phase 1 study.

Microsoft took control of domains that lodged phishing attacks against some users.

The biotech giant says, it will soon begin clinical trials for a different version of the same experimental drug, remdesivir, which might make it easier to administer outside of a hospital or ICU wing.